Therapeutic Treatment of Resveratrol on Alzheimer

1
Therapeutic Treatment of Resveratrol on
Alzheimers Disease with CL2006

• Sohrab Vatsia

2
Need
Alzheimers Incidents in the U.S.
Figure 1
Figure 2
http//uscnews2.usc.edu/Publication_JPGS/HSCWeekly
/2003/HSCW2665p1.jpg
http//www.omh.state.ny.us/omhweb/Statewideplan/20
05/images/figure4.2.gif
3
Alzheimers Disease
Figure 1
Figure 2
Figure 1
http//www.nia.nih.gov/NR/rdonlyres/A294D332-71A2-
4866-BDD7-A0DF216DAAA4/0/Alzheimers_Disease_Unrave
ling_the_Mystery.pdf
http//www.nia.nih.gov/NR/rdonlyres/A294D332-71A2-
4866-BDD7-A0DF216DAAA4/0/Alzheimers_Disease_Unrave
ling_the_Mystery.pdf
Figure 3
http//www.nia.nih.gov/NR/rdonlyres/A294D332-71A2-
4866-BDD7-A0DF216DAAA4/0/Alzheimers_Disease_Unrave
ling_the_Mystery.pdf
4
Resveratrol
http//www.resveratrol.org.uk/resveratrol.gif

• Rogers, Kara, ed. "Alzheimer's Disease."
  Encyclopedia Britannica. 15th ed. 2002. 306-07.

5
Resveratrols Role
http//www.chiro.org/nutrition/ABSTRACTS/Resveratr
ol_in_Prevention_and_Treatment.pdf
6
CL2006
http//wormsrus.50webs.com/Nematodes/C20elegans.J
PG
7
Literature Review

• Marambaud, 2008

(Marambaud, 2008)
8
Literature Review

• Vingtdeux, 2005

(ONeill, 2002)
9
Literature Review

• Anekonda, 2006

(Rodgers, 2006)
10
Literature Review

• Duchen, 2004

(Marambaud, 2005)
11
Hypothesis/ Purpose

• The purpose of the experiment is to analyze the
  therapeutic and preventative potential of
  Resveratrol on Alzhemiers disease.
• Alternate - with the administration of
  Resveratrol in the CL 2006 model, amyloid-beta
  production will slow, and the spread of the
  amyloid-beta molecules will reduce.
• Null - There will be no change in amyloid beta
  production nor paralysis with the addition of
  Resveratrol.

12
Protocols

• Preparation of Bacterial Plates (Siernagle, 2009)

(Yun, 2007)
13
Protocols

• Resveratrol Administration (Halliwell, 2004)
• Concentration ltor to 100 micromolars

(Lenker, 2001)
14
Protocols

• C. elegans synchronization
• Paralyzed versus Non-Paralyzed

(Cheng,2002)
15
Protocols

• Staining using Congo Red Dye-registers Amyloid
  Beta Plaques

(Zhao, 1999)
16
Do-Ability

• This project is do-able because we have all the
  necessary materials in the lab
• C. elgegans (both CL 2006 and wild-type) are
  readily available as well as their environments
  ie plates, food, living conditions
• Resveratrol is also readily available, it can be
  purchased relatively easily
• Amyloid Stain is readily available
• Microscope/s are available along with the prism
  and a Motic camera are also readily available
  thus observation is do-able

17

18
C. Elegans Control
CL 2006 Control
CL 2006 Resveratrol (Preventative)
CL 2006 Resveratrol Therapeutic
CL 2006 Gamma-Secretase
C. Elegans adminstered Resveratrol(negative
control)
Treat on the onset of paralysis. Measure
lifespan, stain, and measure amyloid-beta levels
Tested in order to make sure that the
amyloid-beta is being targeted (2 or 3 trials)
Monitor Life Span, Stain, and obeserve
amyloid-beta levels
Treat with Resveratrol prior to paralysis.
Measure Lifespan, stain,and measure amyloid-beta
levels.
Monitor Lifespan
Stain and monitor amyloid levels, as well as
monitor lifespan
Record Qualitative and Quantitative Data based
upon the observations, and following the
protocols, (Lifespan, Amyloid-Beta Levels)
Statistical Analysis by Two Way Anova followed by
Scheffe Post-Hoc (plt.05)
19
Bibliography

• Bundschuh, K. "The worm in humans." 11 Nov. 2008.
  Biotechnology and Life Sciences in
  Baden-Württemberg. 6 May 2009 lthttp//www.bio-pro.
  de/magazin/wissenschaft/archiv_2008/index.html?lan
  genartikelid/artikel/00452/index.htmlgt.
• Cheng, Louse. Compound in Red Wine May Fight
  Alzeimers. WebMD. 4 Nov. 2005. 15 Apr. 2009
  lthttp//www.webmd.com/alzheimers/news/20051104/com
  pound-in-red-wine-may-fight-alzheimergt.
• Duchen, Michael R. "Roles of Mitochondria in
  Health and Disease." Whereas some of the genes
  identified in the control of longevity appear to
  target mitochondria or at least to alter
  antioxidant defenses of the cell (Duchen, 2004.
  2004. Diabetes. 7 May 2009 lthttp//diabetes.diabet
  esjournals.org/cgi/content/full/53/suppl_1/S96gt.
• Halliwell, Barry, and John M.C. Gutteridge. Free
  Radicals in Biology and Medicine. 3rd ed. New
  York Oxford UP, 2004.
• Lagouge, Marie, Carmen Argmann, Zachary
  Gerhart-Hines, Hamid Meziane, Carles Lerin,
  Frederic Daussin, Nadia Messadeq, Jill Milne,
  Philip Lambert, Peter Elliott, Bernard Geny,
  Markku Laakso, Pere Puigserver, and Johan Auwerx.
  "Resveratrol Improves Mitochondrial Function and
  Protects Against Metabolic Disease by Activating
  SIRT1 and PGC-1a." Cell (2006). 20 May 2008.
• Lenker, David P. Professional Guide to Diseases.
  8th ed. New York Williams Wilkins., 2005
• Marambaud, Phillipe. Wine Compound May Help Cut
  Risk of Alzheimers Disease. 16 Nov.
• 2005. 24 Apr. 2009 lthttp//www.sciencedaily.com/re
  leases/2008/06/080617165716.htmgt.
• McKenzie, Maureen A. "Insulin Receptor-Like
  Protein." Patent Storm. 5 Oct. 1992. 18 Apr.
  2008.
• O,Neill, Bill. "In Methuselahs Mould." Feature 2
  (2004) 0014-017. PLoS Biology.
  lthttp//www.culturagalega.org/imaxes/docs/plos_lon
  xevidade.pdfgt.
• "Resveratrol Studies Suggest Broad Implications
  for SIRT1 Activation,in Neurodegenerative
  Diseases of Aging Such as Alzheimer's Disease (
  whether any of the Company's product ca...)."
• Bio-Medicine - latest biology and medical
  news/technology. 26 June 2007. 29 Apr. 2009
  lthttp//www.bio-medicine.org/medicine-technology/R
  esveratrol-Studies-Suggest-Broad-Implications-for-
  SIRT1-Activation-0Ain-Neurodegenerative-Diseases-o
  f-Aging-Such-as-Alzheimers-Disease-189-3/gt.